FDA PMA Approvals
Premarket Approval devices tracked by MedTracker
PMA
2016-11-30
PMA
2016-11-30
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
View Details →
PMA
2016-11-30
Assay, enzyme linked immunosorbent, hepatitis c virus
View Details →
PMA
2016-11-29
Implant, cochlear
View Details →
PMA
2016-11-29
SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS
View Details →
PMA
2016-11-28
Dorsal root ganglion stimulator for pain relief
View Details →
PMA
2016-11-28
Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented
View Details →
PMA
2016-11-22
Acid, hyaluronic, intraarticular
View Details →
PMA
2016-11-22
Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions
View Details →
PMA
2016-11-22
Lenses, soft contact, extended wear
View Details →
PMA
2016-11-22
Absorbable coronary drug-eluting stent
View Details →
PMA
2016-11-22
Somatic gene mutation detection system
View Details →No matching devices.
Page 53 of 78